The association between Helicobacter pylori infection and the immune response to CVD 103-HgR live oral cholera vaccine

被引：0
|
作者：
Muhsen, K. [1 ]
Sow, S. O. [2 ]
Tapia, M. D. [3 ,4 ]
Reymann, M. [3 ,4 ]
Pasetti, M. F. [3 ,4 ]
Levine, M. M. [3 ,4 ]
机构：
[1] Tel Aviv Univ, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel
[2] Ctr Dev Vaccins, Bamako, Mali
[3] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Inst Global Hlth, Baltimore, MD 21201 USA
来源：
HELICOBACTER | 2019年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P6.21
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Age-Dependent Association among Helicobacter pylori Infection, Serum Pepsinogen Levels and Immune Response of Children to Live Oral Cholera Vaccine CVD 103-HgR
    Muhsen, Khitam
    Lagos, Rosanna
    Reymann, Mardi K.
    Graham, David Y.
    Pasetti, Marcela F.
    Levine, Myron M.
    [J]. PLOS ONE, 2014, 9 (01):
  • [2] Home Administration of CVD 103-HgR: A Live Attenuated Oral Cholera Vaccine
    Duffin, Ryan Paul
    Delbuono, Michael
    Chew, Lawrence
    Johnstone, James
    Nieden, Volker
    Schwarz, Pascal
    Shabram, Paul
    Patel, Amish A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 104 (04): : 1232 - 1240
  • [3] Development of Pediatric Dosage Preparation for CVD 103-HgR Live Oral Cholera Vaccine
    Duffin, R. Paul
    Delbuono, Michael
    Nishioka, Kylie
    Shabram, Paul
    Patel, Amish A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2022, 107 (02): : 388 - 392
  • [4] Update on CVD 103-HgR single-dose, live oral cholera vaccine
    McCarty, James
    Bedell, Lisa
    De Lame, Paul-Andre
    Cassie, David
    Lock, Michael
    Bennett, Sean
    Haney, Douglas
    [J]. EXPERT REVIEW OF VACCINES, 2022, 21 (01) : 9 - 23
  • [5] PaxVax CVD 103-HgR single-dose live oral cholera vaccine
    Levine, Myron M.
    Chen, Wilbur H.
    Kaper, James B.
    Lock, Michael
    Danzig, Lisa
    Gurwith, Marc
    [J]. EXPERT REVIEW OF VACCINES, 2017, 16 (03) : 197 - 213
  • [6] Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults
    Khitam Muhsen
    Samba O. Sow
    Milagritos D. Tapia
    Fadima C. Haidara
    Mardi Reymann
    Valeria Asato
    Wilbur H. Chen
    Marcela F. Pasetti
    Myron M. Levine
    [J]. Scientific Reports, 10
  • [7] Successful comeback of the single-dose live oral cholera vaccine CVD 103-HgR
    Herzog, Christian
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2016, 14 (04) : 373 - 377
  • [8] Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults
    Muhsen, Khitam
    Sow, Samba O.
    Tapia, Milagritos D.
    Haidara, Fadima C.
    Reymann, Mardi
    Asato, Valeria
    Chen, Wilbur H.
    Pasetti, Marcela F.
    Levine, Myron M.
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [9] Immunogenicity of partial doses of live oral cholera vaccine CVD 103-HgR in children in the United States
    McCarty, James M.
    Cassie, David
    Bedell, Lisa
    [J]. VACCINE, 2023, 41 (17) : 2739 - 2742
  • [10] Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR
    Cooper, PJ
    Chico, ME
    Losonsky, G
    Sandoval, C
    Espinel, I
    Sridhara, R
    Aguilar, M
    Guevara, A
    Guderian, RH
    Levine, MM
    Griffin, GE
    Nutman, TB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04): : 1199 - 1206
12345